COPD Therapeutics

The objective of COPD therapeutics is to enhance a patient's functional status and quality by protecting optimal lung function, enhancing indications, and keeping the recurrence of COPD exacerbations. At present, no medicines aside from lung transplantation have been appeared to significantly enhance lung function or decrease mortality; however, oxygen therapy and smoking cessation may decrease mortality. Once the diagnosis of COPD is established, it is essential to educate the patient about the sickness and to empower their active interest in treatment. Bronchodilators are the foundation of any COPD treatment regimen. They work by enlarging aviation routes, accordingly diminishing airsac protection. Pulmonary Conferences provides a multidisciplinary to pulmonology researchers.

    Related Conference of COPD Therapeutics

    April 27-28, 2026

    2nd World Congress on Pathology and Laboratory Medicine

    Paris, Aland Islands
    June 11-12, 2026

    5th World Summit on COPD

    Rome, Italy

    COPD Therapeutics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in